REGN vs SAFE · P/E 14, rev $14.34B vs P/E 11, rev $365.7M
Regeneron Pharmaceuticals Inc (REGN) versus Safehold Inc (SAFE) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Safehold Inc (SAFE) is a reit - diversified company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SAFE revenue for 2024-12-31 was $365.7M. Net income was $106.6M. Revenue was up 3.7% from 2023-12-31 to 2024-12-31. SAFE currently screens at market cap $1.10B and trailing P/E 10.5.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SAFE currently screens at market cap $1.10B and trailing P/E 10.5.
Not investment advice. Open the REGN and SAFE stock pages for the full models.
Not investment advice.